Please use this identifier to cite or link to this item:
|Title:||Pretreatment with intravitreal triamcinolone before laser for diabetic macular edema: 6-month results of a randomized, placebo-controlled trial||Authors:||Gillies, M.C.
|Issue Date:||May-2010||Citation:||Gillies, M.C., McAllister, I.L., Zhu, M., Wong, W., Louis, D., Arnold, J.J., Wong, T.Y. (2010-05). Pretreatment with intravitreal triamcinolone before laser for diabetic macular edema: 6-month results of a randomized, placebo-controlled trial. Investigative Ophthalmology and Visual Science 51 (5) : 2322-2328. ScholarBank@NUS Repository. https://doi.org/10.1167/iovs.09-4400||Abstract:||Purpose. To determine whether pretreatment with intravitreal triamcinolone acetonide (IVTA) before laser photocoagulation is effective in eyes with diabetic macular edema (DME). Methods. The study was a prospective, double-masked, placebo- controlled, clinical trial of eyes with DME and impaired vision (≤20/40) randomized to IVTA 4 mg versus placebo 6 weeks before laser treatment. The main outcome measure was the proportion of eyes with improvement of best-corrected logarithm of minimum angle of resolution (logMAR) visual acuity of ≥5 letters after 6 months. Secondary outcomes were necessity of further treatment, change in central macular thickness, and incidence of adverse events. Results. Eighty-four eyes of 54 participants were entered into the study, with 6-month data available for 81 (96%) of 84 eyes. Improvement of ≥5 logMAR letters was similar in eyes treated with IVTA before laser as placebo (18/42 [43%] IVTA vs. 16/34 [38%] laser alone; P=0.807), as were retreatment rates at 6 months (22 [56%] IVTA vs. 21 [53%] laser alone; P=0.727). Mean central macular thickness decreased by 50 μm (95% confidence interval, 10-96 μm) more in the IVTA treatment group than in the laser-alone group after 6 months (P=0.016). Glaucoma therapy was necessary more frequently in IVTAtreated eyes than in those treated with laser alone (19/42 [45%] vs. 7/42 [17%]; P=0.005). Conclusions. Visual results and the need for further laser treatment at 6 months were no better in the IVTA group than in the laser-alone group, despite a better anatomic outcome reflected by reduction in mean central macular thickness. This study found no evidence of a synergistic effect of IVTA and laser photocoagulation for DME. © Association for Research in Vision and Ophthalmology.||Source Title:||Investigative Ophthalmology and Visual Science||URI:||http://scholarbank.nus.edu.sg/handle/10635/109531||ISSN:||01460404||DOI:||10.1167/iovs.09-4400|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Oct 12, 2021
WEB OF SCIENCETM
checked on Oct 12, 2021
checked on Oct 14, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.